CORC

浏览/检索结果: 共12条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303. 期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:  Si Xiaoyan;  Zhang Li;  Wang Hanping;  Zhang Xiaotong;  Wang Mengzhao
收藏  |  浏览/下载:35/0  |  提交时间:2019/11/19
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. 期刊论文
JAMA oncology, 2018, 卷号: 4, 页码: 1569-1575
作者:  Han Baohui;  Li Kai;  Wang Qiming;  Zhang Li;  Shi Jianhua
收藏  |  浏览/下载:5/0  |  提交时间:2019/11/26
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment 期刊论文
CANCER BIOLOGY & MEDICINE, 2018, 卷号: 15, 页码: 443-451
作者:  Wang, Jing;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:5/0  |  提交时间:2019/11/26
Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer 期刊论文
LUNG CANCER, 2018, 卷号: 122, 页码: 32-37
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载:3/0  |  提交时间:2019/11/26
Downregulation of P38 phosphorylation correlates with low-grade differentiation and proliferation of lung squamous cell carcinoma 期刊论文
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 卷号: 9, 页码: 1922-1933
作者:  Nan, Yandong;  Chang, Ruijing;  Jiang, Hua;  Yang, Shuanying;  Jin, Faguang
收藏  |  浏览/下载:4/0  |  提交时间:2019/11/26
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 页码: S886-S887
作者:  Han, Baohui;  Li, Kai;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载:9/0  |  提交时间:2019/11/26
Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
LANCET ONCOLOGY, 2017, 卷号: 18, 页码: S3-S3
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhao, Yizhuo;  Zhang, Li
收藏  |  浏览/下载:10/0  |  提交时间:2019/11/26
Early Candidate Biomarkers of Non-Small Cell Lung Cancer Are Screened and Identified in Premalignant Lung Lesions 期刊论文
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2017, 卷号: 16, 页码: 66-74
作者:  Nan, Yandong;  Du, Jie;  Ma, Lijie;  Jiang, Hua;  Jin, Faguang
收藏  |  浏览/下载:2/0  |  提交时间:2019/11/26
Application of bronchoscopic argon plasma coagulation in the treatment of tumorous endobronchial tuberculosis: Historical controlled trial 期刊论文
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 卷号: 145, 期号: [db:dc_citation_issue], 页码: 1650-1653
作者:  Jin, Faguang;  Mu, Deguang;  Xie, Yonghong;  Fu, Enqing;  Guo, Youmin
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/10
3,5,4 '-Tri-O-acetylresveratrol attenuates seawater aspiration-induced lung injury by inhibiting activation of nuclear factor-kappa B and hypoxia-inducible factor-1 alpha 期刊论文
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2013, 卷号: 185, 期号: [db:dc_citation_issue], 页码: 608-614
作者:  Ma, Lijie;  Zhao, Yilin;  Li, Beixi;  Wang, Qingwei;  Liu, Xueying
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/10


©版权所有 ©2017 CSpace - Powered by CSpace